Oppenheimer cuts target for Boston Scientific stock from USD 85.00 to USD 65.00
Published on 10/05/2026 at 15:31 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Oppenheimer cut its target for Boston Scientific stock from USD 85.00 to USD 65.00 on September 21, 2026, according to MarketBeat. The move came as Boston Scientific dealt with a cybersecurity incident that disrupted manufacturing, order processing and shipments.
Cyberattack reset the outlook
As MarketScreener reported on September 8, 2026, Boston Scientific said the incident was likely to prevent it from meeting its previously issued third-quarter and full-year 2026 sales and adjusted profit forecasts.
The company plans to provide an updated outlook with its third-quarter results on October 28, 2026, according to the same MarketScreener report. That date gives investors a defined checkpoint for the operational recovery and revised financial outlook.
Second-quarter beat had limits
Boston Scientific reported USD 5.44 billion in revenue for the second quarter of 2026, up 7.50 percent from the same period a year earlier, according to MarketBeat. Adjusted earnings per share reached USD 0.86, above the USD 0.83 analyst consensus, while revenue exceeded the USD 5.38 billion expectation.
The contrast matters: Boston Scientific entered the cyberattack with a measurable second-quarter earnings beat, but the disruption shifted attention from near-term execution to the timing of a recovery. The company has also set third-quarter adjusted earnings guidance at USD 0.80 to USD 0.82 per share.
Stock remains near its yearly low
Boston Scientific has a market capitalization of USD 63.3 billion as of October 5, 2026. Its stock was trading at EUR 38.00 at Lang & Schwarz on October 5, 2026 at 3:18 p.m. CEST, up 0.34 percent versus the prior close of EUR 37.87.
The further course of trading is shown by the continuously updated real-time quote of Boston Scientific stock.
Boston Scientific stock facts
- Company: Boston Scientific Corporation
- ISIN: US1011371077
- WKN: 884113
- Ticker: BSX
- Primary exchange: NYSE
- Price Lang & Schwarz (as of October 5, 2026, 3:18 p.m. CEST): EUR 38.00
- Change versus prior close: plus 0.34 percent
- Prior close Lang & Schwarz (October 2, 2026): EUR 37.87
- Market capitalization: USD 63.3 billion (as of October 5, 2026)
- Sector / Industry: Healthcare / Medical Devices
